Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
BOLT BIOTHERAPEUTICS INC
About BOLT
Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing immunotherapies for the treatment of cancer. The Company’s pipeline includes BDC-3042, an agonist antibody that activates macrophages by targeting dectin-2, and BDC-4182, a next generation Boltbody Immune-Stimulating Antibody Conjugate (ISAC) clinical candidate targeting claudin 18.2. BDC-3042 is in a Phase I dose escalation trial that includes patients with any of seven different solid tumor types. The Company’s Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. It has two additional ISAC programs utilizing its Boltbody ISAC technology platform in preclinical development. One is a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5 (CEA). Its final Boltbody ISAC program targets PD-L1. The Company is also developing additional Boltbody ISACs in strategic collaborations with biopharmaceutical companies.
Find out what a historical investment in BOLT BIOTHERAPEUTICS INC would be worth today using our BOLT stock calculator.
Market Capitalisation
$9.07M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
4.84K
High today
$4.80
Low today
$4.62
Open price
$4.80
52-week high
$7.35
52-week low
$3.91
Ready to start your investing journey with Stake?
Open an accountHow do I buy BOLT shares in Australia?
Buying BOLT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in BOLT BIOTHERAPEUTICS INC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in BOLT
What is the ticker symbol of BOLT BIOTHERAPEUTICS INC?
The ticker symbol for BOLT BIOTHERAPEUTICS INC is BOLT.
How much is one share of BOLT?
One share of BOLT is valued at $4.62 as of 10 June 2026.
What is the market capitalisation of BOLT BIOTHERAPEUTICS INC BOLT?
As of 10 June 2026 BOLT BIOTHERAPEUTICS INC has a market cap of $9.07M.
What is the 52-week high for BOLT BIOTHERAPEUTICS INC stock?
The BOLT BIOTHERAPEUTICS INC 52-week high stock price is $7.35.
What is the 52-week low for BOLT BIOTHERAPEUTICS INC stock?
The BOLT BIOTHERAPEUTICS INC 52-week low stock price is $3.91.
Can I buy BOLT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy BOLT shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in BOLT on Stake
- Buy BOLT from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of BOLT from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
BOLT related stocks